Filing Details

Accession Number:
0001209191-15-028985
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-24 18:10:38
Reporting Period:
2015-03-23
Filing Date:
2015-03-24
Accepted Time:
2015-03-24 18:10:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197032 F Ian Smith C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-03-23 200 $122.44 123,976 No 4 S Direct
Common Stock Disposition 2015-03-23 200 $123.52 123,776 No 4 S Direct
Common Stock Disposition 2015-03-23 1,327 $124.87 122,449 No 4 S Direct
Common Stock Disposition 2015-03-23 2,815 $125.69 119,634 No 4 S Direct
Common Stock Disposition 2015-03-23 1,000 $126.65 118,634 No 4 S Direct
Common Stock Disposition 2015-03-23 500 $127.83 118,134 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,306 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $122.44 (range $122.10 to $122.78).
  3. Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $123.52 (range $123.10 to $123.93).
  5. Open market sales reported on this line occurred at a weighted average price of $124.87 (range $124.28 to $125.24).
  6. Open market sales reported on this line occurred at a weighted average price of $125.69 (range $125.28 to $126.24).
  7. Open market sales reported on this line occurred at a weighted average price of $126.65 (range $126.29 to $127.07).
  8. Open market sales reported on this line occurred at a weighted average price of $127.83 (range $127.39 to $128.19).